Glaxosmithkline | Capital Ordinário



Ordinary Share Capital Alterar Data
AbbVie USD 18M 0 2024-12
Amgen USD 538M 33.04B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Aurora Cannabis CAD 6.98B 907K 2024-12
Bausch Health Companies USD 369.75M 10.14B 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 105.29M 105.15M 2025-06
Drreddys Laboratories INR 834M 0 2024-12
Eli Lilly USD 592.6M 200K 2025-03
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 6.56B 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Prestige Brands USD 49.21M 48.65M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
Supernus Pharmaceuticals USD 56.12M 130K 2025-06
Takeda JPY 1.56B 1.69T 2025-06
Teva Pharmaceutical Industries USD 1.15B 1.09B 2025-06
Zoetis USD 443.95M 438.95M 2025-06


Glaxosmithkline Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.